Literature DB >> 22050511

Endoscopic assessment and prediction of prostate urethral disintegration after histotripsy treatment in a canine model.

George R Schade1, Nicholas R Styn, Timothy L Hall, William W Roberts.   

Abstract

BACKGROUND AND
PURPOSE: Histotripsy is a nonthermal focused ultrasound technology that uses acoustic cavitation to homogenize tissue. Previous research has demonstrated that the prostatic urethra is more resistant to histotripsy effects than prostate parenchyma, a finding that may complicate the creation of transurethral resection of the prostate-like treatment cavities. The purpose of this study was to characterize the endoscopic appearance of the prostatic urethra during and after histotripsy treatment and to identify features that are predictive of urethral disintegration.
MATERIALS AND METHODS: Thirty-five histotripsy treatments were delivered in a transverse plane traversing the prostatic urethra in 17 canine subjects (1-3/prostate ≥1 cm apart). Real-time endoscopy was performed in the first four subjects to characterize development of acute urethral treatment effect (UTE). Serial postprocedure endoscopy was performed in all subjects to assess subsequent evolution of UTE.
RESULTS: Endoscopy during histotripsy was feasible with observation of intraurethral cavitation, allowing characterization of the real-time progression of UTE from normal to frank urethral disintegration. While acute urethral fragmentation occurred in 3/35 (8.6%) treatments, frank urethral disintegration developed in 24/35 (68.5%) within 14 days of treatment. Treating until the appearance of hemostatic pale gray shaggy urothelium was the best predictor of achieving urethral fragmentation within 14 days of treatment with positive and negative predictive values of 0.91 and 0.89, respectively.
CONCLUSION: Endoscopic assessment of the urethra may be a useful adjunct to prostatic histotripsy to help guide therapy to ensure urethral disintegration, allowing drainage of the homogenized adenoma and effective tissue debulking.

Entities:  

Mesh:

Year:  2011        PMID: 22050511      PMCID: PMC3311909          DOI: 10.1089/end.2011.0349

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  14 in total

Review 1.  Current treatment options for benign prostatic hyperplasia and their impact on sexual function.

Authors:  Thayne R Larson
Journal:  Urology       Date:  2003-04       Impact factor: 2.649

2.  Microbubble-enhanced cavitation for noninvasive ultrasound surgery.

Authors:  Binh C Tran; Jongbum Seo; Timothy L Hall; J Brian Fowlkes; Charles A Cain
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2003-10       Impact factor: 2.725

3.  Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney.

Authors:  Kathleen Kieran; Timothy L Hall; Jessica E Parsons; J Stuart Wolf; J Brian Fowlkes; Charles A Cain; William W Roberts
Journal:  J Urol       Date:  2007-06-15       Impact factor: 7.450

4.  Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.

Authors:  Sascha A Ahyai; Karin Lehrich; Rainer M Kuntz
Journal:  Eur Urol       Date:  2007-04-25       Impact factor: 20.096

5.  Update on AUA guideline on the management of benign prostatic hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn; Andrew L Avins; Michael J Barry; Reginald C Bruskewitz; Robert F Donnell; Harris E Foster; Chris M Gonzalez; Steven A Kaplan; David F Penson; James C Ulchaker; John T Wei
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

6.  Acoustic access to the prostate for extracorporeal ultrasound ablation.

Authors:  Timothy L Hall; Christopher R Hempel; Brian J Sabb; William W Roberts
Journal:  J Endourol       Date:  2010-08-02       Impact factor: 2.942

7.  Histotripsy fractionation of prostate tissue: local effects and systemic response in a canine model.

Authors:  Christopher R Hempel; Timothy L Hall; Charles A Cain; J Brian Fowlkes; Zhen Xu; William W Roberts
Journal:  J Urol       Date:  2011-02-19       Impact factor: 7.450

8.  Urologic diseases in America project: benign prostatic hyperplasia.

Authors:  John T Wei; Elizabeth Calhoun; Steven J Jacobsen
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

9.  Prostate histotripsy in an anticoagulated model.

Authors:  Jeffery C Wheat; Timothy L Hall; Christopher R Hempel; Charles A Cain; Zhen Xu; William W Roberts
Journal:  Urology       Date:  2009-11-22       Impact factor: 2.649

10.  Histotripsy of the prostate: dose effects in a chronic canine model.

Authors:  Timothy L Hall; Christopher R Hempel; Kirk Wojno; Zhen Xu; Charles A Cain; William W Roberts
Journal:  Urology       Date:  2009-07-22       Impact factor: 2.649

View more
  6 in total

1.  Prostate histotripsy: evaluation of prostatic urethral treatment parameters in a canine model.

Authors:  George R Schade; Nicholas R Styn; Kimberly A Ives; Timothy L Hall; William W Roberts
Journal:  BJU Int       Date:  2013-10-31       Impact factor: 5.588

2.  A Prototype Therapy System for Transcutaneous Application of Boiling Histotripsy.

Authors:  Adam D Maxwell; Petr V Yuldashev; Wayne Kreider; Tatiana D Khokhlova; George R Schade; Timothy L Hall; Oleg A Sapozhnikov; Michael R Bailey; Vera A Khokhlova
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2017-08-14       Impact factor: 2.725

3.  Urethral-sparing histotripsy of the prostate in a canine model.

Authors:  George R Schade; Timothy L Hall; William W Roberts
Journal:  Urology       Date:  2012-07-26       Impact factor: 2.649

Review 4.  Development and translation of histotripsy: current status and future directions.

Authors:  William W Roberts
Journal:  Curr Opin Urol       Date:  2014-01       Impact factor: 2.309

Review 5.  Minimally invasive devices for treating lower urinary tract symptoms in benign prostate hyperplasia: technology update.

Authors:  Fouad Aoun; Quentin Marcelis; Thierry Roumeguère
Journal:  Res Rep Urol       Date:  2015-08-19

6.  Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound.

Authors:  Zhen Xu; Timothy L Hall; Eli Vlaisavljevich; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2021       Impact factor: 3.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.